Stock ENDV ENDONOVO THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Endonovo Therapeutics, Inc.

Equities

ENDV

US29272H3003

Delayed OTC Markets
Other stock markets
 20:46:23 02/07/2024 BST 		5-day change 1st Jan Change
0.0009 USD -16.67% Intraday chart for Endonovo Therapeutics, Inc. -18.18% -89.66%
2023 Endonovo Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 Endonovo Therapeutics, Inc 's Sofpulse® Secures Taiwan FDA Approval CI
1227b6aca879ebaa4650.M2BuxPeOy2kXSoNgViXAvF4gVOPYHLGD1iJ5A0kHxmY.QA0EiJL9lCJActkDMhefjjtiGtWacIXxvw9ITSV_sBVFISq-js-zClw4wg~19ae846162eb5bc7d5a8ae5a7e4171c0
  1. Stock Market
  2. Equities
  3. ENDV Stock
  4. Charts Endonovo Therapeutics, Inc.
  5. News Chart